Patient Power®
Get Email Alerts!
Health Topics
Multiple Myeloma Health Center
Health Center Home Audio Programs Videos Conference Coverage
  • ASH 2011
    • Live Events
  • SCCA Myeloma Town Hall 2011
    • Search by Keyword:
    Search by Health Topic:
    View all Health Topics >
    Spring Survey 2012 Results

    The Latest Clinical Trial News for Myeloma

    PROGRAM DETAILS:

    2008 looks to be an exciting time for the continued rapid development of effective treatment combinations. With numerous drug approvals in the last four years and more coming, myeloma specialists are beginning to establish a “backbone” of effective drug therapies. This seventh program in the Patient Power multiple myeloma series features Dr. Paul Richardson, clinical director of the Jerome Lipper Center for Multiple Myeloma at the Dana-Farber Cancer Institute in Boston, and Dr. Asher Chanan-Khan, an attending physician in the Department of Medicine at Roswell Park Cancer Institute in Buffalo, N.Y. Both doctors agree this is a pivotal time for myeloma patients to consider participating in trials as we move to more effective treatments, leading to longer lives.

    You’ll hear opinions from both doctors on the controversy surrounding transplant, and why they feel strongly about their views. Learn how clinical trials are helping researchers understand new combinations of drugs, which combination is right for which patient and when, and how to find a clinical trial that’s right for you. Questions from listeners are also addressed, including how to reduce side effects, stem cell therapy, myeloma as a secondary cancer and an explanation of high-risk myeloma.

    Dr. Richardson and Dr. Chanan-Khan share their optimism for the future, where research is headed and how the field has advanced in recent years. This program gives a positive outlook for the future and insight on the latest research and treatments for Myeloma. Dr. Chanan-Khan states, “I hope that the listeners have a better insight of the efforts and the importance of the clinical trials, and thank you for participating, because without their support and their courage things would not have changed as they have today.”

    Get Email Updates:

    Get updated automatically when new content about Multiple Myeloma has been posted.
    Privacy Policy
    Multiple MyelomaMore Health Topics
    EXPERTS & GUESTS:
    Paul Richardson, M.D. Paul Richardson, M.D.
    Clinical Director, Jerome Lipper Center for Multiple Myeloma , Dana-Farber Cancer Institute
    Dr. Richardson is Associate Professor of Medicine at Harvard Medical School, as well as Clinical Director of the Jerome Lipper Center for Multiple Myeloma at the Dana-Farber Cancer Institute in Boston and Chairman of the American Myeloma Research Consortiom. He received his medical degree from the Medical College of St. Bartholomew's Hospital, University of London, and completed residency training at... more >

    Asher Chanan-Khan, M.D. Asher Chanan-Khan, M.D.
    Attending Physician in the Department of Medicine, Roswell Park Cancer Institute
    Dr. Asher Chanan-Khan is an Attending Physician in the Department of Medicine at Roswell Park Cancer Institute (RPCI) and Assistant Professor in the Department of Medicine at the University of Buffalo School of Medicine & Biomedical Sciences. Dr. Chanan-Khan graduated from Allama Iqbal Medical College of Punjab University in Pakistan and went on to complete residency training in Internal Medicine... more >

    TRANSCRIPT:

    1. Introduction LISTEN
    2. Stem Cell Transplantation LISTEN
    3. Who Should Participate in a Clinical Trial? LISTEN
    4. Questions from Listeners LISTEN

    RELATED LINKS: